WQ7 Stock Overview
Develops, sells, and distributes licensed veterinary pharmaceuticals and identification products, and services for companion and production animals, and equine veterinary markets in Europe and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Animalcare Group plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£2.72 |
| 52 Week High | UK£2.74 |
| 52 Week Low | UK£1.85 |
| Beta | 0.48 |
| 1 Month Change | 12.40% |
| 3 Month Change | 24.77% |
| 1 Year Change | 36.00% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -20.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| WQ7 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 8.8% | -0.8% | -1.0% |
| 1Y | 36.0% | -19.2% | 6.4% |
Return vs Industry: WQ7 exceeded the German Pharmaceuticals industry which returned -19.2% over the past year.
Return vs Market: WQ7 exceeded the German Market which returned 6.4% over the past year.
Price Volatility
| WQ7 volatility | |
|---|---|
| WQ7 Average Weekly Movement | 4.9% |
| Pharmaceuticals Industry Average Movement | 5.4% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: WQ7 has not had significant price volatility in the past 3 months.
Volatility Over Time: WQ7's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 220 | Jenny Winter | www.animalcaregroup.com |
Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals and identification products, and services for companion and production animals, and equine veterinary markets in Europe and internationally. It also offers microchipping and other associated services. Animalcare Group plc is based in York, the United Kingdom.
Animalcare Group plc Fundamentals Summary
| WQ7 fundamental statistics | |
|---|---|
| Market cap | €172.98m |
| Earnings (TTM) | €1.41m |
| Revenue (TTM) | €87.31m |
122.9x
P/E Ratio2.0x
P/S RatioIs WQ7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WQ7 income statement (TTM) | |
|---|---|
| Revenue | UK£74.35m |
| Cost of Revenue | UK£31.01m |
| Gross Profit | UK£43.35m |
| Other Expenses | UK£42.15m |
| Earnings | UK£1.20m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.02 |
| Gross Margin | 58.30% |
| Net Profit Margin | 1.61% |
| Debt/Equity Ratio | 3.8% |
How did WQ7 perform over the long term?
See historical performance and comparisonDividends
2.0%
Current Dividend Yield251%
Payout RatioDoes WQ7 pay a reliable dividends?
See WQ7 dividend history and benchmarks| Animalcare Group dividend dates | |
|---|---|
| Ex Dividend Date | Jun 20 2024 |
| Dividend Pay Date | Jul 19 2024 |
| Days until Ex dividend | 26 days |
| Days until Dividend pay date | 55 days |
Does WQ7 pay a reliable dividends?
See WQ7 dividend history and benchmarks